AIVITA Biomedical Receives FDA Approval for Phase 2 Ovarian Cancer Treatment
IRVINE, C.A., June 21, 2016 – AIVITA Biomedical, a therapeutic development company focused on regenerative and curative medicines, today…
AIVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
IRVINE, C.A., June 10, 2016 — AIVITA Biomedical, a therapeutic development company focused on regenerative and curative medicines, today announced…